Change search criteria ↓

Search results

348 projects found matching your search criteria:

  1. 1. Radiosensitization by the combined use of modified nucleosides and inhibitors of DNA repair to improve the efficacy of r…

    Principal investigator: dr Magdalena Danuta Zdrowowicz-Żamojć

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 17, Panel: ST4

  2. 2. Proteins of dry-cured pork loins with the addition of a probiotic bacterial strain as a potential source od peptides wit…

    Principal investigator: dr Paulina Maria Kęska

    Uniwersytet Przyrodniczy w Lublinie, Wydział Nauk o Żywności i Biotechnologii

    Call: PRELUDIUM 15, Panel: NZ9

  3. 3. Early Intervention with mTOR Inhibitors for Neuropsychiatric Symptoms in Tuberous Sclerosis Complex: Unveiling Developme…

    Principal investigator: prof. Ewelina Anna Knapska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: DAINA 3, Panel: NZ4

  4. 4. An influence of lipoproteins on fibrinolysis and pleiotropic effect of proprotein convertase subtilisin/kexin type 9 (PC…

    Principal investigator: Magdalena Teresa Kopytek

    Krakowski Szpital Specjalistyczny im. Jana Pawła II

    Call: PRELUDIUM 20, Panel: NZ5

  5. 5. Aminophosphonates bearing fluorine atoms as inhibitors odf aminopeptideses and their potential application for determina…

    Principal investigator: prof. Paweł Kazimierz Kafarski

    Politechnika Wrocławska

    Call: HARMONIA 9, Panel: ST5

  6. 6. Cardioprotective effect of inhibitors of matrix metalloproteinase-2 (MMP-2) and inhibitors of posttanslational modificat…

    Principal investigator: prof. Mieczysław Woźniak

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

    Call: HARMONIA 3, Panel: NZ3

  7. 7. The study of synergistic inhibition of tumor cell proliferation by CK2 casein kinase inhibitors and inhibitors of thymid…

    Principal investigator: prof. Maria Wanda Bretner

    Politechnika Warszawska, Wydział Chemiczny

    Call: OPUS 7, Panel: NZ7

  8. 8. Pattern-Specific Inhibitors (PSI) - introduction and basic characteristics of a new class of inhibitors that block recog…

    Principal investigator: dr Krzysztof Guzik

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 3, Panel: NZ6

  9. 9. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t…

    Principal investigator: Shaoshan Mai

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: PRELUDIUM 20, Panel: NZ7

  10. 10. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha…

    Principal investigator: dr Dawid Marcin Panek

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  11. 11. The use of olaparib and ATR / CHK1 kinase inhibitors as a targeted anti-cancer therapy based on synthetic lethality

    Principal investigator: dr hab. Aneta Katarzyna Rogalska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: SONATA BIS 9, Panel: NZ7

  12. 12. Biased inverse agonists of 5-HT6 receptor and dual 5-HT6/MAO-B inhibitors - in search for new therapeutic approaches for…

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 11, Panel: NZ7

  13. 13. Multifunctional inhibitors of beta-secretase with anti-aggregating properties of neurotoxic peptides - beta-amyloid and …

    Principal investigator: prof. Barbara Antonina Malawska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 11, Panel: NZ7

  14. 14. Development and study of peptide inhibitors of membrane fusion in flaviviruses, based on the STEM region of the tick-bor…

    Principal investigator: Krzysztof Polaczek

    Uniwersytet Gdański

    Call: PRELUDIUM 24, Panel: NZ6

  15. 15. Inhibitors of the non-mevalonate isoprenoid biosynthesis pathway - a new class of antibiotics against tuberculosis and m…

    Principal investigator: dr Ignacy Przemysław Janicki

    Centrum Badań Molekularnych i Makromolekularnych PAN

    Call: SONATA 20, Panel: ST5

  16. 16. Novel insights into inhibition of PD-L1/PD-1 immune checkpoint – discovery and optimization of covalent PD-L1 inhibitors…

    Principal investigator: dr Radosław Dariusz Kitel

    Uniwersytet Jagielloński

    Call: SONATA 20, Panel: ST5

  17. 17. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

    Call: SONATA 20, Panel: NZ5

  18. 18. Human exosomes as natural carriers of protein kinase CK2 inhibitors and degraders in targeted anticancer therapy.

    Principal investigator: dr hab. Patrycja Joanna Wińska

    Politechnika Warszawska

    Call: OPUS 28 (LAP), Panel: NZ5

  19. 19. Analysis of pharmacokinetic, pharmacodynamic and molecular determinants of intolerance and resistance to the Janus kinas…

    Principal investigator: prof. Marta Katarzyna Karaźniewicz-Łada

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 27, Panel: NZ7

  20. 20. Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout

    Principal investigator: dr Monika Katarzyna Rola

    Politechnika Łódzka

    Call: PRELUDIUM 23, Panel: ST4

  21. 21. Innovative Small Molecule Inhibitors Targeting LAG-3 and MHCII Complex for Tumour Immunotherapy

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

    Call: OPUS 27, Panel: NZ7

  22. 22. Controlling the covalent activity of a PD-L1 inhibitors with light

    Principal investigator: Wiktor Jan Uzar

    Uniwersytet Jagielloński

    Call: PRELUDIUM 23, Panel: NZ7

  23. 23. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t…

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki

    Call: OPUS 27, Panel: NZ7

  24. 24. Novel aspects of the mechanisms of vascular toxicity of tyrosine kinase inhibitors: studies on their proinflammatory act…

    Principal investigator: dr Tomasz Krzysztof Prajsnar

    Uniwersytet Jagielloński, Wydział Biologii

    Call: OPUS 26, Panel: NZ5

  25. 25. Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA BIS 13, Panel: NZ7

  26. 26. Theoretical prediction, chemical synthesis and biological analysis of a novel class of HSPA5 inhibitors

    Principal investigator: prof. Arkadiusz Chworoś

    Centrum Badań Molekularnych i Makromolekularnych PAN

    Call: OPUS 25, Panel: ST4

  27. 27. Investigating the mechanisms of CD20 downregulation triggered by tyrosine kinase inhibitors in Philadelphia chromosome-p…

    Principal investigator: Krzysztof Domka

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 22, Panel: NZ5

  28. 28. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design…

    Principal investigator: Emilia Aleksandra Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  29. 29. Designing Active Inhibitors of SARS-CoV-2 Methyltransferases

    Principal investigator: Alex Jun Matsuda

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: PRELUDIUM 22, Panel: NZ7

  30. 30. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit…

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

    Call: SONATA 18, Panel: NZ7

  31. 31. Development of a cell-based assay for screening of SARS-CoV-2 PLpro inhibitors

    Principal investigator: dr Wioletta Katarzyna Rut-Schedlok

    Politechnika Wrocławska

    Call: SONATA 18, Panel: NZ6

  32. 32. Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier in…

    Principal investigator: dr hab. Aneta Iwona Radziwon-Balicka

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: POLONEZ BIS 3, Panel: NZ7

  33. 33. Identification of key structural elements of immunomodulatory proteins - inhibitors of antigenic peptide transporter TAP…

    Principal investigator: dr Natalia Anna Karska

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 18, Panel: NZ7

  34. 34. The role of diet in the development of autoimmune diseases - new interleukin 15 inhibitors among dietary polyphenols and…

    Principal investigator: dr Barbara Joanna Żyżyńska-Granica

    Warszawski Uniwersytet Medyczny

    Call: SONATA 18, Panel: NZ9

  35. 35. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

    Principal investigator: Dawid Dariusz Dorna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 21, Panel: NZ7

  36. 36. Pharmacogenomics of SGLT2 inhibitors - investigating the role of empagliflozin in epigenetic modification of non-coding …

    Principal investigator: Anna Nowak-Szwed

    Warszawski Uniwersytet Medyczny

    Call: PRELUDIUM 21, Panel: NZ7

  37. 37. The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on changes in selected epigenetic mechan…

    Principal investigator: Agnieszka Magdalena Woźniak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 21, Panel: NZ7

  38. 38. Structure-guided design of histone demethylase inhibitors for cancer therapy.

    Principal investigator: dr Piotr Henryk Małecki

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 17, Panel: NZ7

  39. 39. Small-molecule inhibitors of protein aggregation and ER stress as a novel strategy against neurodegeneration in the cour…

    Principal investigator: prof. Ireneusz Jacek Majsterek

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM BIS 3, Panel: NZ5

  40. 40. Search for Inhibitors of Human δ1-Pyrroline-5-Carboxylate Reductase 1 (PYCR1) as Lead Molecules for the Development of N…

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 22, Panel: NZ7

  41. 41. Research on the influence of medicines of the angiotensin-converting enzyme inhibitors (ACEI) group on the choroidal and…

    Principal investigator: Jowita Zwolska

    Uniwersytet Przyrodniczy w Lublinie, Wydział Medycyny Weterynaryjnej

    Call: PRELUDIUM 20, Panel: NZ4

  42. 42. Design of high selective and safe juvenile hormone epoxide hydrolases inhibitors targeting selected pests based on the c…

    Principal investigator: dr hab. Artur Wiktor Góra

    Politechnika Śląska, Centrum Biotechnologii

    Call: OPUS 20, Panel: ST4

  43. 43. Iron chelators as tyrosine kinase inhibitors - a new strategy for the treatment of glioblastoma multiforme

    Principal investigator: dr hab. Anna Dominika Mrozek-Wilczkiewicz

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

    Call: PRELUDIUM BIS 2, Panel: NZ5

  44. 44. Changes in lipid metabolism of resistant to BRAF/MEK inhibitors human melanoma cells associated with the presence of adi…

    Principal investigator: dr Aleksandra Simiczyjew

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: SONATA 16, Panel: NZ5

  45. 45. Modulation of ATP production using glycolysis inhibitors in cancer cells monitored by novel biosensing systems based on …

    Principal investigator: Katarzyna Cecylia Ratajczak

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

    Call: PRELUDIUM 19, Panel: ST4

  46. 46. Role of cereal leaf beetle – associated bacteria in the adaptation of their insect host to the insecticides and protease…

    Principal investigator: dr Beata Wielkopolan

    Instytut Ochrony Roślin - Państwowy Instytut Badawczy

    Call: PRELUDIUM 19, Panel: NZ9

  47. 47. Exploring the allosteric regulation of the SARS CoV-2 hydrolases using methyl-TROSY NMR spectroscopy - in search of nove…

    Principal investigator: prof. Wiktor Adam Koźmiński

    Uniwersytet Warszawski, Wydział Chemii

    Call: OPUS 19, Panel: ST4

  48. 48. New steroid sulfatase inhibitors based on 1,2,4-oxadiazole sulfamate derivatives

    Principal investigator: Karol Andrzej Biernacki

    Politechnika Gdańska, Wydział Chemiczny

    Call: PRELUDIUM 19, Panel: NZ7

  49. 49. Inhalable polymeric delivery systems of antibiotics and quorum sensing inhibitors for the treatment of respiratory infec…

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

    Call: OPUS 18, Panel: ST5

  50. 50. Molecular mechanisms of interplay between RORγ/RORγT receptors and cyclin-dependent kinase inhibitor (AT7519). Analysis …

    Principal investigator: Kaja Urszula Karaś

    Instytut Biologii Medycznej PAN

    Call: PRELUDIUM 18, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski